As most people point out, its not going to get nailed. It was trading around $3.70 equivalent on close. On Friday the US was trading around $4.80 equivalent. It had a lot to give back.
This remains, in my view, an incredibly appropriate treatment to the inflammatory story behind COIVD-19 deaths (not just ARDS I hope, as inflammatory incidents now started to been seen in children in UK studies alas). It not so much losing money on this I care about now. What I care about now is this treatment falling out of focus and a load of crappy drugs being instigated instead, which do little to address the underlying problem (unlike Remestemcel-L) and cause loads of bad side effects - you watch Gilead's Remedisivir cause renal issues....
In MSB for the long run (already was as of 2018 anyway) in the hope it really does get taken up, in a world where physicians are scratching their heads, trying all sorts of different approaches to a pandemic that is presenting in so many different ways (kidney, brain and heart failure as well as, and in tandem, with ARDS)
- Forums
- ASX - By Stock
- Today gonna be bloodbath
As most people point out, its not going to get nailed. It was...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $4.059M | 3.437M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 31654 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 31439 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 32998 | 1.155 |
18 | 117579 | 1.150 |
14 | 96678 | 1.145 |
15 | 248050 | 1.140 |
6 | 138423 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 27313 | 5 |
1.165 | 86862 | 11 |
1.170 | 76914 | 11 |
1.175 | 6888 | 2 |
1.180 | 45423 | 7 |
Last trade - 13.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |